2025-10-15T12:45:27-05:00 2024-12-31 260794367 UHY ADVISORS MID-ATLANTIC INC 8601 ROBERT FULTON DRIVE SUITE 210 COLUMBIA MD 21046 990 2024-01-01 752816066 THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC MESO 8773636376 1717 K STREET NW 900 WASHINGTON DC 20006 DARCIENA ANDERSON CHRISTEL TREASURER 8773636376 2025-10-10 1 1 KATSIARYNA VASILIEV P02167272 4107205220 2025-10-10 2024 2025-03-06 01:10:19Z DARCIENA ANDERSON CHRISTE 1717 K STREET NW 900 WASHINGTON DC 20006 7362057 0 X WWW.CUREMESO.ORG X 1999 DC TO OFFER HOPE AND SUPPORT TO MESOTHELIOMA CANCER PATIENTS AND THEIR FAMILIES THROUGH EDUCATION, FUNDING OF QUALITY, PEER-REVIEWED RESEARCH, AND RAISE PUBLIC AWARENESS. 10 10 7 32 0 0 944461 746645 476947 590735 122229 679349 3232 1417 1546869 2018146 472278 391290 0 0 633760 605637 0 0 138373 426185 406143 1532223 1403070 14646 615076 9971454 10638848 546462 554608 9424992 10084240 X THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. MISSION IS TO OFFER HOPE AND SUPPORT TO PATIENTS AND FAMILIES DEALING WITH MESOTHELIOMA. THIS IS ACCOMPLISHED BY EDUCATING PATIENTS AND FAMILIES ABOUT THE DISEASE, HELPING THEM OBTAIN THE MOST UP-TO-DATE INFORMATION ON TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS, AND PROVIDING ASSISTANCE, EMOTIONAL SUPPORT, AND COMMUNITY WITH OTHERS. THE FOUNDATION PROVIDES FUNDING TO THE HIGHEST QUALITY AND MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS WORLDWIDE THROUGH RIGOROUS PEER-REVIEW. THE FOUNDATION ALSO WORKS TO RAISE AWARENESS OF THE DISEASE, AND ADVOCATES THAT THE PUBLIC AND PRIVATE SECTORS PARTNER IN THE EFFORT TO CURE IT BY DIRECTING THE RESOURCES NEEDED TO STOP THIS GLOBAL TRAGEDY. 0 0 518110 90776 590735 EDUCATION SUPPORT AND SYMPOSIUM - PATIENT SUPPORT SERVICES OFFERED BY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. INCLUDE PERSONALIZED CONSULTATIONS AND GUIDANCE THROUGH TREATMENT WITH MESOTHELIOMA EXPERTS. THIS INCLUDES PROVIDING PATIENTS WITH INFORMATION ABOUT TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS WHEN NEEDED, AND FACILITATING ACCESS TO THE FOUNDATION'S SUPPORT GROUPS. 390648 300348 RESEARCH - THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. FUNDS THE MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS GLOBALLY, AS DETERMINED BY A RIGOROUS PEER-REVIEW PROCESS VIA THE FOUNDATION'S SCIENCE ADVISORY BOARD AND APPROVED BY THE BOARD OF DIRECTORS. THIS PROCESS IS BASED UPON THE DEPARTMENT OF DEFENSE CDMRP. BASED UPON THE NATIONAL CANCER INSTITUTE, THE MESOTHELIOMA FOUNDATION HAS FUNDED 97 GRANTS, AWARDING $9.6 MILLION IN FUNDING RESEARCH GRANTS TO DATE. 20952 166 ADVOCACY - THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. ADVOCATES ON BEHALF OF ITS PATIENTS AND FAMILIES FOR INCREASED FUNDING OF MESOTHELIOMA RESEARCH THROUGH FEDERAL INVESTMENT. 929710 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 6 0 7 1 0 0 0 0 0 0 0 0 0 0 X 10 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AK AL AR CA CO CT GA HI IL KS KY MA MD ME MN MS NC NJ NV NY OH OK OR PA RI SC TN VA WA WI WV NM X X THE ORGANIZATION 8773636376 1717 K STREET NW WASHINGTON DC 20036 MARJORIE G ZAUDERER MD MS FACP CHAIR 1.00 X X 0 0 0 DARCIENA ANDERSON CHRISTEL TREASURER 1.00 X X 0 0 0 R TAYLOR RIPLEY MD VICE CHAIR 1.00 X X 0 0 0 KEITH CENGEL MD PHD SECRETARY 1.00 X 0 0 0 JASON M FOSTER MD DIRECTOR 1.00 X 0 0 0 AARON S MANSFIELD MD DIRECTOR (STEPPED DOWN IN 2024) 1.00 X 0 0 0 SANJAY POPAT PHD DIRECTOR (STEPPED DOWN IN 2024) 1.00 X 0 0 0 BORIS SEPESI MD DIRECTOR (MEMBERSHIP PAUSED IN 2024) 1.00 X 0 0 0 DANIEL STERMAN MD DIRECTOR 1.00 X 0 0 0 JAMES STEVENSON MD DIRECTOR 1.00 X 0 0 0 WILLIAM N ZIEGLER DIRECTOR 1.00 X 0 0 0 CHERYL BRUNER ESQ DIRECTOR 1.00 X 0 0 0 JESSICA BLACKFORD-CLEETON DIRECTOR 1.00 X 0 0 0 BRIAN T LEPACEK EXECUTIVE DIRECTOR 40.00 X 53910 0 0 JULIE WHITE HIGHEST COMPENSATED EMPLOYEE 40.00 X 127500 0 5419 181410 0 5419 1 0 0 0 0 746645 243100 746645 EDUCATIONAL PROGRAMMING 541900 575000 575000 SYMPOSIUM EVENTS 541900 15735 15735 590735 395288 395288 5627972 5343911 284061 284061 284061 OTHER INCOME 900099 1417 1417 1417 2018146 592152 0 679349 200000 200000 91290 91290 100000 100000 186829 131670 23143 32016 263571 185753 32650 45168 12281 7155 3400 1726 108570 69259 22331 16980 34386 24799 3572 6015 56851 24418 26451 5982 60635 60635 35016 3000 32016 17287 8044 7289 1954 37846 137 37672 37 24033 7497 3109 13427 1740 1406 4 330 23208 948 22181 79 10475 475 10000 908 908 7303 1339 5624 340 EVENTS 111427 71329 27908 12190 BANK AND CREDIT CARD FE 10594 9203 1391 DUES AND SUBSCRIPTIONS 2917 2917 TELEPHONE 2340 604 1727 9 3563 587 2247 729 1403070 929710 334987 138373 1701726 1060296 1240925 2375916 143490 26101 992 19915 13004 10306 1243 2698 6879001 7153922 4077 0 9971454 10638848 80497 34893 388750 467500 77215 52215 546462 554608 X 9424992 10084240 9424992 10084240 9971454 10638848 615076 44172 0 X X 0 1 X 1 0 X 5100939 2386366 1243523 944461 746785 10422074 5100939 2386366 1243523 944461 746785 10422074 1293520 9128554 65079 210606 220837 269826 395288 1161636 140 3232 1417 4789 11588499 0.78770 0.83570 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13004 10306 2698 2698 X 2001683 44172 44172 1957511 60635 60635 2018146 1342435 0 1342435 60635 60635 1403070 PART X, LINE 2: THE INCOME TAX POSITIONS TAKEN BY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. FOR ANY YEARS OPEN UNDER THE VARIOUS STATUTES OF LIMITATIONS ARE THAT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. CONTINUES TO BE EXEMPT FROM INCOME TAXES AND THAT THEY HAVE PROPERLY REPORTED UNRELATED BUSINESS INCOME THAT IS SUBJECT TO INCOME TAXES. MANAGEMENT BELIEVES THAT THERE ARE NO TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD SIGNIFICANTLY INCREASE WITHIN 12 MONTHS OF THE REPORTING DATE. THE FOUNDATION'S FEDERAL AND STATE INCOME TAX RETURNS ARE NOT CURRENTLY UNDER EXAMINATION. 0 EUROPE - LONDON GRANTS TO RECIPIENTS RESEARCH 100000 0 0 0 0 0 0 100000 0 100000 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 100000 WIRE 0 0 0 0 0 0 0 1 BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS STREET BOSTON MA 02115 042312909 100000 0 RESEARCH GRANT THE UNIVERSITY OF CHICAGO 5841 S MARYLAND AVE MC 2026 CHICAGO IL 60637 362177139 100000 0 RESEARCH GRANT PATIENT TRAVEL 91290 X 14698 243100 FMV 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS REVIEWED AND APPROVED BY THE TREASURER AND EXECUTIVE DIRECTOR, THEN SUBMITTED TO THE FULL BOARD PRIOR TO BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST FORMS ARE REQUIRED TO BE FILLED OUT EACH YEAR AND ARE PUBLISHED IN THE BOARD OF DIRECTORS FOLDER AT EACH MEETING. FORM 990, PART VI, SECTION B, LINE 15A EXECUTIVE COMPENSATION IS DETERMINED BY THE BOARD OF DIRECTORS BASED UPON THE EXECUTIVE DIRECTOR'S HISTORICAL COMPENSATION AND RELATIVELY MINOR AND INFREQUENT ADJUSTMENTS BASED UPON GROWTH, SUCCESS, AND INCREASING COMPLEXITY OF THE ORGANIZATION. CHANGES TO THE EXECUTIVE COMPENSATION ARE APPROVED IN THE MINUTES. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS ARE AVAILABLE AT THE ORGANIZATION'S OFFICE DURING BUSINESS HOURS, WITH AN APPOINTMENT AND BY REQUEST VIA EMAIL OR MAIL. FORM 990, PART XII, LINE 2C THE BOARD TREASURER OVERSEES THE SELECTION OF AN INDEPENDENT AUDITOR. THE OVERSIGHT AND SELECTION PROCESS DID NOT CHANGE FROM THE PRIOR YEAR.